Bank of America’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-99,105
| Closed | -$2.39M | – | 7111 |
|
2023
Q1 | $2.39M | Buy |
99,105
+49,399
| +99% | +$1.19M | ﹤0.01% | 3582 |
|
2022
Q4 | $525K | Sell |
49,706
-17,471
| -26% | -$185K | ﹤0.01% | 4656 |
|
2022
Q3 | $303K | Sell |
67,177
-7,484
| -10% | -$33.8K | ﹤0.01% | 4968 |
|
2022
Q2 | $298K | Buy |
74,661
+21,761
| +41% | +$86.9K | ﹤0.01% | 5076 |
|
2022
Q1 | $388K | Sell |
52,900
-49,926
| -49% | -$366K | ﹤0.01% | 5282 |
|
2021
Q4 | $578K | Buy |
102,826
+62,725
| +156% | +$353K | ﹤0.01% | 4995 |
|
2021
Q3 | $256K | Buy |
40,101
+2,898
| +8% | +$18.5K | ﹤0.01% | 5305 |
|
2021
Q2 | $313K | Sell |
37,203
-8,518
| -19% | -$71.7K | ﹤0.01% | 5032 |
|
2021
Q1 | $479K | Buy |
45,721
+18,418
| +67% | +$193K | ﹤0.01% | 4792 |
|
2020
Q4 | $462K | Sell |
27,303
-17,185
| -39% | -$291K | ﹤0.01% | 4380 |
|
2020
Q3 | $571K | Sell |
44,488
-17,735
| -29% | -$228K | ﹤0.01% | 4060 |
|
2020
Q2 | $877K | Buy |
62,223
+35,521
| +133% | +$501K | ﹤0.01% | 3749 |
|
2020
Q1 | $246K | Buy |
26,702
+19,702
| +281% | +$182K | ﹤0.01% | 4425 |
|
2019
Q4 | $105K | Buy |
7,000
+1,532
| +28% | +$23K | ﹤0.01% | 5168 |
|
2019
Q3 | $37K | Buy |
5,468
+5,043
| +1,187% | +$34.1K | ﹤0.01% | 5587 |
|
2019
Q2 | $5K | Buy |
+425
| New | +$5K | ﹤0.01% | 6060 |
|
2019
Q1 | – | Sell |
-739
| Closed | -$1K | – | 6527 |
|
2018
Q4 | $1K | Buy |
+739
| New | +$1K | ﹤0.01% | 6233 |
|